$3.76
-0.17-4.33%
Last update: Nov 5, 6:10 PM
MannKind Corp (MNKD) Stock Price, Quote, News & History
MNKDNASDAQ
MannKind licenses Technosphere GLP-1 tech to Rose Pharma for weight management development.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MannKind has a consensus price target of $9.10.
The stock price for MannKind (NASDAQ: MNKD) is $3.5499 last updated November 5, 2026 at 6:10 PM EST.
There are no upcoming dividends for MannKind.
MannKind does not have any upcoming earnings scheduled.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical...
